News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
110,503 Results
Type
Article (2716)
Company Profile (24)
Press Release (107763)
Section
Business (43582)
Career Advice (75)
Deals (6811)
Drug Delivery (5)
Drug Development (12606)
Employer Resources (9)
FDA (2201)
Job Trends (2309)
News (62878)
Policy (3649)
Tag
2027 Biotech Bay Standard (1)
2027 Pharm Country Standard (1)
Academia (230)
Accelerated approval (12)
Allergies (35)
Alliances (4877)
ALS (22)
Alzheimer's disease (247)
Antibody-drug conjugate (ADC) (67)
Approvals (2371)
Artificial intelligence (49)
Autoimmune disease (33)
Automation (3)
Bankruptcy (28)
Best Places to Work (2178)
Biosimilars (28)
Biotechnology (17)
Bladder cancer (71)
Brain cancer (5)
Breast cancer (170)
Cancer (1082)
Cardiovascular disease (78)
Career advice (69)
Career pathing (4)
CAR-T (45)
Cell therapy (117)
Cervical cancer (8)
Clinical research (11760)
Collaboration (179)
Compensation (142)
Complete response letters (6)
COVID-19 (214)
CRISPR (11)
C-suite (49)
Cystic fibrosis (12)
Data (1506)
Denatured (1)
Depression (16)
Diabetes (69)
Diagnostics (1188)
Digital health (5)
Diversity (1)
Drug discovery (16)
Drug pricing (6)
Drug shortages (5)
Duchenne muscular dystrophy (29)
Earnings (37081)
Employer branding (1)
Employer resources (7)
Events (15363)
Executive appointments (56)
FDA (2938)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (1)
Frontotemporal dementia (10)
Funding (160)
Gene editing (22)
Generative AI (5)
Gene therapy (67)
GLP-1 (129)
Government (360)
Grass and pollen (1)
Guidances (276)
Healthcare (3023)
HIV (14)
Huntington's disease (10)
IgA nephropathy (25)
Immunology and inflammation (46)
Immuno-oncology (12)
Indications (32)
Infectious disease (244)
Inflammatory bowel disease (30)
Inflation Reduction Act (1)
Influenza (11)
Intellectual property (36)
Interviews (7)
IPO (4922)
IRA (2)
Job creations (276)
Job search strategy (60)
JPM (4)
Kidney cancer (5)
Labor market (15)
Layoffs (51)
Legal (620)
Liver cancer (17)
Longevity (1)
Lung cancer (149)
Lymphoma (118)
Machine learning (4)
Management (2)
Manufacturing (79)
MASH (47)
Medical device (2716)
Medtech (2726)
Mergers & acquisitions (2054)
Metabolic disorders (202)
mRNA (23)
Multiple sclerosis (50)
NASH (6)
Neurodegenerative disease (46)
Neuropsychiatric disorders (13)
Neuroscience (469)
NextGen: Class of 2026 (791)
Non-profit (411)
Now hiring (4)
Obesity (81)
Opinion (15)
Ovarian cancer (54)
Pain (30)
Pancreatic cancer (44)
Parkinson's disease (44)
Partnered (4)
Patents (62)
Patient recruitment (40)
Peanut (13)
People (4463)
Pharmaceutical (10)
Pharmacy benefit managers (7)
Phase 1 (3133)
Phase 2 (4879)
Phase 3 (4639)
Pipeline (2045)
Policy (7)
Postmarket research (360)
Preclinical (1074)
Press Release (1)
Prostate cancer (53)
Radiopharmaceuticals (34)
Rare diseases (111)
Real estate (411)
Recruiting (6)
Regulatory (3315)
Reports (13)
Research institute (235)
Resumes & cover letters (8)
Rett syndrome (9)
RSV (10)
Schizophrenia (35)
Series A (26)
Series B (11)
Service/supplier (1)
Sickle cell disease (14)
Special edition (4)
Spinal muscular atrophy (34)
Sponsored (4)
Startups (300)
Stomach cancer (2)
Supply chain (10)
Tariffs (4)
The Weekly (3)
Vaccines (100)
Venture capital (9)
Weight loss (52)
Women's health (17)
Worklife (2)
Date
Today (21)
Last 7 days (250)
Last 30 days (673)
Last 365 days (6326)
2026 (971)
2025 (6353)
2024 (7063)
2023 (8291)
2022 (10050)
2021 (11405)
2020 (10139)
2019 (7111)
2018 (5612)
2017 (5400)
2016 (4011)
2015 (5360)
2014 (3664)
2013 (2217)
2012 (2442)
2011 (3011)
2010 (2549)
Location
Africa (89)
Alabama (8)
Alaska (2)
Arizona (53)
Arkansas (1)
Asia (5323)
Australia (1404)
California (2444)
Canada (799)
China (186)
Colorado (88)
Connecticut (91)
Delaware (89)
Europe (15574)
Florida (326)
Georgia (79)
Hawaii (1)
Idaho (5)
Illinois (152)
India (7)
Indiana (145)
Iowa (2)
Japan (120)
Kansas (20)
Kentucky (6)
Louisiana (12)
Maine (45)
Maryland (293)
Massachusetts (1517)
Michigan (63)
Minnesota (178)
Missouri (20)
Montana (4)
Nebraska (1)
Nevada (31)
New Hampshire (13)
New Jersey (693)
New York (669)
North Carolina (222)
North Dakota (2)
Northern California (1299)
Ohio (49)
Oklahoma (2)
Oregon (1)
Pennsylvania (565)
Puerto Rico (10)
Rhode Island (1)
South America (156)
South Carolina (3)
Southern California (953)
Tennessee (27)
Texas (268)
United States (8244)
Utah (62)
Virginia (38)
Washington D.C. (4)
Washington State (176)
Wisconsin (18)
110,503 Results for "41".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Belite Bio Announces Participation at the 41st Asia-Pacific Academy of Ophthalmology Congress (APAO)
January 29, 2026
·
3 min read
Press Releases
Elutia to Present at Global BioInnovation Forum on NXT-41x Biomatrix Program for Plastic and Reconstructive Surgery
January 9, 2026
·
5 min read
Press Releases
Elutia Selects Pete Ligotti as CCO to Lead the Commercial Launch of NXT-41x and Transform Post-Mastectomy Care in the $1.5B U.S. Breast Surgery Market
March 2, 2026
·
7 min read
Press Releases
Elutia Reports Preliminary Fourth Quarter 2025 Results, Strengthened Financial Position, and Upcoming NXT-41x Milestones
January 12, 2026
·
7 min read
Legal
Investment Banker Accused of Leaking Pharma M&A Secrets in $41M Insider Trading Scheme
The banker allegedly shared details of a series of multibillion-dollar buyouts by companies including AbbVie, GSK and Pfizer.
December 23, 2025
·
2 min read
·
Nick Paul Taylor
Press Releases
AI Proteins Raises $41.5M Series A Financing to Advance De Novo Miniproteins as a New Therapeutic Modality
November 20, 2025
·
3 min read
Press Releases
AHF Commends Gov. Newsom for Signing PBM Reform Bill (SB 41, Weiner)
October 13, 2025
·
1 min read
Press Releases
Zelluna Publishes Compelling Preclinical Data for ZI-MA4-1, the World’s First MAGE-A4-Targeting TCR-NK Therapy for Solid Tumours
December 16, 2025
·
4 min read
Press Releases
Successful IMvigor011 Trial Achieves 41% Improvement in Overall Survival for Bladder Cancer Patients
October 20, 2025
·
5 min read
Press Releases
Zelluna Completes First GMP Batch of ZI-MA4-1, a Novel TCR-NK Cell Therapy, to Treat Patients in Upcoming First-in-Human Trial
December 12, 2025
·
3 min read
1 of 11,051
Next
